Rockefeller Capital Management
MRNS

Rockefeller Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Rockefeller Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-250
Closed -$2K – 4465
2022
Q1 		$2K Hold
250
– – ﹤0.01% 3663
2021
Q4 		$2K Hold
250
– – ﹤0.01% 3589
2021
Q3 		$2K Hold
250
– – ﹤0.01% 3501
2021
Q2 		$4K Hold
250
– – ﹤0.01% 3122
2021
Q1 		$3K Hold
250
– – ﹤0.01% 3064
2020
Q4 		$3K Hold
250
– – ﹤0.01% 2603
2020
Q3 		$3K Buy
+250
New +$2.16K ﹤0.01% 2377

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Rockefeller Capital Management's MRNS Position: Q2 2022 in Review

Rockefeller Capital Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2022, closing a stake of 250 shares — an estimated $2K sold.

Rockefeller Capital Management first reported a position in MRNS in Q3 2020 and held it in 7 quarters. The position peaked at $4K in Q2 2021. 73 funds tracked by Wall St. Rank hold MRNS as of Q2 2022.

  • Rockefeller Capital Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 250 Marinus Pharmaceuticals, Inc shares in Q2 2022, an estimated $2K.
  • Rockefeller Capital Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2020 and held it in 7 quarters.
  • Rockefeller Capital Management's Marinus Pharmaceuticals, Inc position peaked at $4K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2022.

Based on Rockefeller Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.